InsidersTradesSigma
Follow the Antengene Corporation Ltd. - B stock price and the full insider trade history of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the supervision of HKEX. Operating in the Health Care sector, Antengene Corporation Ltd. - B has logged 7 public disclosures. Market capitalisation: €2.7bn. The latest transaction was filed on 10 August 2026 (Other). Among the most active insiders: Mei Jay. All data is accessible without an account.
7
Insider Decl.
n/a
Thresholds
€233,128
5 ops.
Buy Volume
n/a
1 ops.
Sell Volume
8Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,104 of 28,958 companies
44.2
score / 100
Value18
Quality70
FCF yld-6.8%
Earn yld-9.1%
EV/EBITDA·
ROE6.4%
Gross mgn84%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 August 2026
Declarations7 total
235,000 shares@ HK$4.1360.0038% mcap48.2% of flowShareXHKGHKEX:DA20260324E00376
640,000 sharesShareXHKGHKEX:DA20260324E00230
267,500 shares@ HK$3.8930.0041% mcap51.8% of flowShareXHKGHKEX:DA20260324E00233
7 of 7 declarations
About Antengene Corporation Ltd. - B
Antengene Corporation Ltd. is a biopharmaceutical company focused on developing innovative cancer treatments. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.